Lpath Inc. (LPTN.OB) Secures Strategic $23M Alliance to Launch Cancer Treatment Trials
Oftentimes money can stand in the way of health. In light of our current economic woes, many individuals find that the rising cost of healthcare outweighs the need for insurance and proper care. The same goes for scientific and medical companies in need of funding for further research and development. To accomplish their mission, many companies form strategic partnerships to obtain cash injections. Such an arrangement was today announced between Lpath Inc. (OTCBB: LPTN) and Merck Serono, a division of Germany-based Merck KGaA. The alliance was fueled by the fact that Merck Serono holds an annual R&D investment of around…